SCHEMBL19166295

SCHEMBL19166295

c1ccc(-c2nc(-c3ccc(-c4cncnc4)cc3)cc(-c3ccc4ccc5cccc6ccc3c4c56)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.41
MEN1 O00255 7/20 0.41
KMT2A Q03164 7/20 0.41
HPGD P15428 7/20 0.41
ALDH1A1 P00352 6/20 0.41
MAPT P10636 6/20 0.41
NTSR1 P30989 1/20 0.41
KDM4E B2RXH2 4/20 0.40
LMNA P02545 2/20 0.40
GLA P06280 1/20 0.40
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
CYP2C19 P33261 1/20 0.35
EPHB4 P54760 1/20 0.35
TEK Q02763 1/20 0.35
CYP19A1 P11511 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19168118 1.00 ATM (0.41) ATMMEN1KMT2AHPGDALDH1A1
SCHEMBL19167353 0.95 ATM (0.41) ATMMEN1KMT2AHPGDALDH1A1
SCHEMBL19166998 0.95 ATM (0.41) ATMMEN1KMT2AHPGDALDH1A1
SCHEMBL19168039 0.95 ATM (0.41) ATMMEN1KMT2AHPGDALDH1A1
SCHEMBL19167007 0.93 ATM (0.44) ATMMEN1KMT2AHPGDALDH1A1
SCHEMBL10051308 0.91 MEN1 (0.49) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL10051209 0.91 MEN1 (0.49) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL19166324 0.89 CYP11B1 (0.46) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL19167652 0.89 CYP11B1 (0.46) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL19166282 0.89 CYP11B1 (0.46) MEN1KMT2AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10797244-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-10-06 US disclosed
US-20170213982-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 US disclosed
US-20170213982-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10797244-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device RER1, RBM12, H1-2 ATM 1880/4885MEN1 1361/4885KMT2A 1244/4885
US-20170213982-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE RER1, RBM12, H1-2 ATM 1880/4885MEN1 1361/4885KMT2A 1244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.